Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer.
Safont MJ, Artal-Cortes A, Sirera R, Gómez-Codina J, González-Larriba JL, Barneto I, Carrato A, Isla D, Rosell R, Camps C. Safont MJ, et al. Lung Cancer. 2009 Jan;63(1):83-7. doi: 10.1016/j.lungcan.2008.04.015. Epub 2008 Jun 13. Lung Cancer. 2009. PMID: 18555556 Clinical Trial.
The antiemetic efficacy of thiethylperazine and methylprednisolone versus thiethylperazine and placebo in breast cancer patients treated with adjuvant chemotherapy (fluorouracil, doxorubicin and cyclophosphamide). A randomized, double-blind, cross-over trial.
Diaz-Rubio E, Martin M, Rosell R, Valerdi JJ, Gonzalez-Larriba JL, Barriga JJ. Diaz-Rubio E, et al. Acta Oncol. 1991;30(3):339-42. doi: 10.3109/02841869109092382. Acta Oncol. 1991. PMID: 2036244 Clinical Trial.
Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
Díaz-Rubio E, González-Larriba JL, Rosell R, Abad A, Martín M, Valerdi JJ, Barriga JJ. Díaz-Rubio E, et al. Ann Oncol. 1990 Sep;1(5):379-80. doi: 10.1093/oxfordjournals.annonc.a057780. Ann Oncol. 1990. PMID: 2261379 Free article. Clinical Trial. No abstract available.
Oral idarubicin in measurable gastric cancer.
Abad-Esteve A, Diaz-Rubio E, Jimeno JM, Rosell R, Villar A, Gonzalez-Larriba JL. Abad-Esteve A, et al. Am J Clin Oncol. 1989 Feb;12(1):14-6. doi: 10.1097/00000421-198902000-00004. Am J Clin Oncol. 1989. PMID: 2912018
[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
González Larriba JL, Alberola V, Lianes P, Panizo A, Carrato A, Muñoz Quintana A, Cardenal F, Gracia JM, Moyano A, Díaz-Rubio E, et al. González Larriba JL, et al. Rev Clin Esp. 1994 Nov;194(11):953-9. Rev Clin Esp. 1994. PMID: 7846351 Clinical Trial. Spanish.
Ifosfamide in advanced epidermoid head and neck cancer.
Martín M, Diaz-Rubio E, González Larriba JL, Casado A, Sastre J, López-Vega JM, Almenarez J, Dominguez S. Martín M, et al. Cancer Chemother Pharmacol. 1993;31(4):340-2. doi: 10.1007/BF00685683. Cancer Chemother Pharmacol. 1993. PMID: 8422700 Clinical Trial.
124 results